Chronic Fatigue in General Practice: Economic Evaluation of Counselling Versus Cognitive Behaviour Therapy
Overview
Affiliations
Background: There is a paucity of evidence relating to the cost-effectiveness of alternative treatment responses to chronic fatigue.
Aim: To compare the relative costs and outcomes of counselling versus cognitive behaviour therapy (CBT) provided in primary care settings for the treatment of fatigue.
Design Of Study: A randomised controlled trial incorporating a cost-consequences analysis.
Setting: One hundred and twenty-nine patients from 10 general practices across London and the South Thames region who had experienced symptoms of fatigue for at least three months.
Method: An economic analysis was performed to measure costs of therapy, other use of health services, informal care-giving, and lost employment. The principal outcome measure was the Fatigue Questionnaire; secondary measures were the Hospital Anxiety and Depression Scale and a social adjustment scale.
Results: Although the mean cost of treatment was higher for the CBT group (164 Pounds, standard deviation = 67) than the counselling group (109 Pounds, SD = 49; 95% confidence interval = 35 to 76, P < 0.001), a comparison of change scores between baseline and six-month assessment revealed no statistically significant differences between the two groups in terms of aggregate health care costs, patient and family costs or incremental cost-effectiveness (cost per unit of improvement on the fatigue score).
Conclusions: Counselling and CBT both led to improvements in fatigue and related symptoms, while slightly reducing informal care and lost productivity costs. Counselling represents a less costly (and more widely available) intervention but no overall cost-effectiveness advantage was found for either form of therapy.
Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?.
Vink M, Vink-Niese F Healthcare (Basel). 2022; 10(2).
PMID: 35207003 PMC: 8872229. DOI: 10.3390/healthcare10020392.
Cochrane M, Mitchell E, Hollingworth W, Crawley E, Trepel D Appl Health Econ Health Policy. 2021; 19(4):473-486.
PMID: 33646528 PMC: 7917957. DOI: 10.1007/s40258-021-00635-7.
Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A Health Technol Assess. 2020; 24(46):1-490.
PMID: 32975190 PMC: 7548871. DOI: 10.3310/hta24460.
Vink M, Vink-Niese F Diagnostics (Basel). 2019; 9(4).
PMID: 31547009 PMC: 6963831. DOI: 10.3390/diagnostics9040124.
Meng H, Friedberg F Fatigue. 2019; 5(4):202-214.
PMID: 30931176 PMC: 6438387. DOI: 10.1080/21641846.2017.1343171.